Acute Respiratory Distress Syndrome Clinical Trial
Official title:
The Pulmonary Vascular Consequences of Divergent Strategies for Low Tidal Volume Ventilation: Hypercapnia or High Respiratory Rate?
The purpose of this protocol is to perform serial physiological measurements and blood testing on mechanically ventilated patients comparing conditions of eucapnia and hypercapnia in the same patient. We will be testing two hypotheses: (1) while administering inspired carbon dioxide (CO2), eucapnia achieved by high respiratory rate (EHR) significantly decreases pulmonary artery pressures compared to hypercapnia with a lower respiratory rate (HLR), and (2) that EHR decreases myocardial strain compared to HLR.
The purpose of this protocol is to perform serial physiological measurements and blood
testing on mechanically ventilated patients comparing conditions of eucapnia (maintaining
alveolar ventilation to target carbon dioxide partial pressure (pCO2) 35-40 mm Hg) and
hypercapnia (providing inspired CO2 to target pCO2 55-60 mm Hg) in the same patient. This
prospective clinical study will enroll consenting adult patients scheduled for elective
cardiac surgery and who require postoperative mechanical ventilation, pulmonary artery
(Swan-Ganz) catheter monitoring, and arterial catheterization as part of routine standard
care during the immediate postoperative period. The study will perform measurements using
available ventilator monitors, ventilator in-line pneumotachograph and capnograph,
measurements from the indwelling pulmonary artery catheter, transesophageal
echocardiography, and other measurements available as part of routine care. The entire
experimental protocol will be performed in one day over 2-4 hours, and the protocol will not
interfere with routine postoperative care, nor prolong the need for mechanical ventilation,
pulmonary artery catheterization, arterial catheterization, or intensive care unit length of
stay.
Ventilation with low tidal volumes has been shown definitively to improve mortality from
acute respiratory distress syndrome (ARDS)1 and may provide benefit even in patients without
ARDS.2 During low tidal volume ventilation, practice varies on whether to allow some degree
of alveolar hypoventilation with incidental hypercapnic acidosis (termed "permissive
hypercapnia"),3 or to increase respiratory rate to maintain alveolar ventilation and target
eucapnia, often requiring respiratory rates > 30/min.4 The physiological consequences of
these divergent strategies remain to be fully elucidated. We propose the following study to
distinguish the effects of a eucapnic high respiratory rate (EHR) strategy from a
hypercapnic low respiratory rate (HLR) strategy on pulmonary hemodynamics during low tidal
volume ventilation.
Specific Aim: To test the hypothesis that, while administering inspired CO2, eucapnia
achieved by high respiratory rate (EHR) significantly decreases pulmonary artery pressures
compared to hypercapnia with a lower respiratory rate (HLR).
Specific Aim: To test the hypothesis that EHR decreases myocardial strain compared to HLR.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A | |
Completed |
NCT02214576 -
High Flow Nasal Canula Oxygen Helps Preoxygenate ARDS Patients
|
N/A |